These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 30783323)

  • 1. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction.
    Mehan S; Monga V; Rani M; Dudi R; Ghimire K
    Indian J Pharmacol; 2018; 50(6):309-319. PubMed ID: 30783323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
    Kumar P; Kumar A
    J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
    Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK
    Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P; Kumar A
    Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations.
    Binawade Y; Jagtap A
    J Med Food; 2013 Oct; 16(10):934-43. PubMed ID: 24138168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial cofactors in experimental Huntington's disease: behavioral, biochemical and histological evaluation.
    Mehrotra A; Sandhir R
    Behav Brain Res; 2014 Mar; 261():345-55. PubMed ID: 24393741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism.
    Malik J; Karan M; Dogra R
    Pharm Biol; 2017 Dec; 55(1):980-990. PubMed ID: 28164735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.
    Hariharan A; Shetty S; Shirole T; Jagtap AG
    Neurotoxicology; 2014 Dec; 45():139-48. PubMed ID: 25445565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.
    Mehrotra A; Sood A; Sandhir R
    Mol Cell Biochem; 2015 Dec; 410(1-2):281-92. PubMed ID: 26374445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain.
    Kumar P; Kalonia H; Kumar A
    Drug Chem Toxicol; 2010 Oct; 33(4):377-92. PubMed ID: 20550427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair-Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax-Bad genes in male wistar rats.
    Thangarajan S; Ramachandran S; Krishnamurthy P
    Biomed Pharmacother; 2016 Dec; 84():514-525. PubMed ID: 27690136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum.
    Thangarajan S; Deivasigamani A; Natarajan SS; Krishnan P; Mohanan SK
    Int J Neurosci; 2014 Sep; 124(9):673-84. PubMed ID: 24325390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington's disease-like symptoms in wistar rats.
    Ramachandran S; Thangarajan S
    Chem Biol Interact; 2016 Aug; 256():25-36. PubMed ID: 27206696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced Huntington's disease in rats.
    Katariya R; Mishra K; Sammeta S; Umekar M; Kotagale N; Taksande B
    Neurotoxicology; 2024 May; 102():12-28. PubMed ID: 38453033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences.
    Kumar A; Chaudhary T; Mishra J
    Eur J Pharmacol; 2013 Nov; 720(1-3):16-28. PubMed ID: 24211676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease.
    Kumar P; Kalonia H; Kumar A
    Behav Pharmacol; 2010 May; 21(3):217-30. PubMed ID: 20480544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective role of PDE4 and PDE5 inhibitors in 3-nitropropionic acid induced behavioral and biochemical toxicities in rats.
    Thakur T; Sharma S; Kumar K; Deshmukh R; Sharma PL
    Eur J Pharmacol; 2013 Aug; 714(1-3):515-21. PubMed ID: 23831390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington's Disease.
    Fotoohi A; Moloudi MR; Hosseini S; Hassanzadeh K; Feligioni M; Izadpanah E
    Neurochem Res; 2021 Jun; 46(6):1372-1379. PubMed ID: 33611726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington's disease.
    Sharma P; Kumar M; Bansal N
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Sep; 394(9):1917-1928. PubMed ID: 34061228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease.
    Gao Y; Chu SF; Li JP; Zhang Z; Yan JQ; Wen ZL; Xia CY; Mou Z; Wang ZZ; He WB; Guo XF; Wei GN; Chen NH
    Acta Pharmacol Sin; 2015 Mar; 36(3):311-22. PubMed ID: 25640478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.